Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.30 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.30 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12463129 | 0.79 | CHRNB2 (0.36) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL179525 | 0.79 | CHRNB2 (0.36) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL17120406 | 0.77 | CHRNB2 (0.35) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL2486077 | 0.76 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL1630761 | 0.76 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL1630764 | 0.76 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL18042843 | 0.75 | CHRNB2 (0.34) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL18042846 | 0.75 | CHRNB2 (0.34) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL25458780 | 0.72 | — | — | |
| SCHEMBL20160346 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070275046-A1 | Noval Surfactants and Applications Thereof | TS PHARMA (FR) | 2007-11-29 | — | — | US | disclosed |
| US-6359006-B2 | ANTIISCHEMIC AGENTS; ANTICANCER AGENTS | ALLIANCE PHARMACEUTICAL CORP. | 2002-03-19 | — | — | US | disclosed |
| US-20020019442-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION PROCEDURE AND BIOMEDICAL APPLICATIONS | PFC THERAPEUTICS, LLC | 2002-02-14 | — | — | US | disclosed |
| US-5847206-A | Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-08 | — | — | US | disclosed |
| US-5703126-A | USED AS MARKER, CARRIERS IN TRANSPORT OF GASES, CONTRAST AGENT, DRUG OR CARRIER FOR DRUG | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5527962-A | FLUOROPOLYMER WITH PERFLUOROALKYL MERCAPTAN END GROUP AS CARRIER FOR DRUG DELIVERY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-06-18 | — | — | US | disclosed |
| EP-0548096-B1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS | ATTA (FR) | 1995-11-08 | — | — | EP | disclosed |
| EP-0548096-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS. | ATTA (FR) | 1993-06-30 | — | — | EP | disclosed |
| WO-1992002560-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHNO (FR) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070275046-A1 | Noval Surfactants and Applications Thereof | SGMS1, SGMS2, ANXA6 | CHRNB2 2646/4885CHRNB4 3140/4885CHRNA3 3019/4885 |
| US-20020019442-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION PROCEDURE AND BIOMEDICAL APPLICATIONS | POT1, TERF2, TELO2 | CHRNB2 687/4885CHRNB4 1424/4885CHRNA3 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.